Verdicts & Settlements

Pfizer Settles Lawsuits over Dopamine Drugs

pfizer settles dopamine lawsuitsThe pharmaceutical giant Pfizer has settled a class-action lawsuit claiming the company did not adequately warn patients of the potential health risks posed by its dopamine drugs Cabaser and Dostinex. According to the FiercePharma article, Pfizer reached a multi-million dollar confidential settlement with 172 patients in an Australian court.

Plaintiffs in the class-action lawsuit claimed that Pfizer’s Cabaser and Dostinex caused them to develop previously nonexistent addictions to activities ...

continue reading...

Lopez McHugh IVC Trial Ends With Settlement

On January 26, 2015, Lopez McHugh represented a plaintiff in the second lawsuit in the nation to proceed to trial against Bard for its defective inferior vena cava filters. Ramon Rossi Lopez was lead trial counsel in the case, which involved a Recovery Filter that migrated to and punctured a hole in the plaintiff’s heart, leading to emergency open heart surgery. After 11 days of trial, Bard made a confidential settlement offer, which was accepted ...

continue reading...

Boston Scientific Wins its First Trial Over Vaginal Mesh Injuries

The first of a series of trials regarding Boston Scientific’s vaginal mesh devices has ended in the company’s favor. Bloomberg reports that a Massachusetts jury found that the plaintiff had not proven that Boston Scientific’s vaginal mesh device, named Pinnacle mesh, was defectively designed. The jury also found that the plaintiff failed to demonstrate that the warnings about the inherent risks of the device were inadequate.

Over 12,000 lawsuits have been filed against ...

continue reading...

Shire Settlement over Drug Marketing Totals $56.5 Million

In a recent announcement from the U.S. Department of Justice, a whistle-blower lawsuit against the major pharmaceutical company Shire resulted in a $56.5 million settlement. An article in First Word Pharma reports that the Shire CEO is “pleased to have reached a resolution” over the improper marketing of a number of its drugs.

The lawsuit claims that the company “violated the False Claims Act by improperly marketing and promoting several drugs.” The claim alleged ...

continue reading...

U.S. District Court Dismisses F.D.A. Whistleblower Suit

A recent decision by a U.S. District Court Judge dismissed a whistleblower lawsuit filed by six current and former scientists at the U.S. Food and Drug Administration (FDA). The employees had complained about the safety of various medical devices that came through the FDA. After doing so, they found that their private communications were being secretly monitored by FDA officials. The Washington Post reports that although the claim and its ramifications “troubled” the ...

continue reading...

Pfizer’s Illegal Drug Marketing Charges Settle for $35 million

Pfizer subsidiary Wyeth settles marketing claims for 35 billion dollarsWyeth Pharmaceuticals, a subsidiary of Pfizer, was charged with illegally marketing a drug that was not cleared for use by the FDA. A story in Reuters reports that Wyeth illegally marketed its organ transplant drug Rapamune for conditions it was not approved to treat.

The charges indicated that Wyeth trained and encouraged sales representatives to promote Rapamune for uses other than preventing rejection ...

continue reading...
Page 2 of 15 12345...»